selective class IIa HDAC inhibitor (ASINEX)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameselective class IIa HDAC inhibitor (ASINEX)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 2 inhibitors
TargetsHistone deacetylase 2
Therapy Area/IndicationsSolid tumoursCentral Nervous System NeoplasmsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesASINEX Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesASINEX Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursCentral Nervous System NeoplasmsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A